The marginally higher incidence of CD34 positivity that we observed in malignant nodules compared to benign lesions contradicted previous results from comparable investigations, such as the study by Jiang et al. In that study, malignant tumours showed less CD34 expression than benign lesions [37]. The gene discussed is CD34; the disease is cancer.